2-(3,4-epoxycyclohexyl)ethyltriethoxysilane

CAS : 10217-34-2

Ref. 3D-KAA21734

Informations sur le produit

• Nom: 2-(3,4-epoxycyclohexyl)ethyltriethoxysilane
• Synonymes: (2-(7-Oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane, 1,2-Epoxy-4-(2-triethoxysilylethyl)cyclohexane, 3-[2-(Triethoxysilyl)ethyl]-7-oxabicyclo[4.1.0]heptane, 7-Oxabicyclo(4.1.0)heptane, 3-(2-(triethoxysilyl)ethyl)-, 7-Oxabicyclo[4.1.0]heptane, silane deriv., A 1861, Add 107, Ccris 3045, Cg 0186, CoatOSil 1770, CoatOSil A 1770, CoatOSil Y 11988, Db 1770, Kh 1770, Kh 567, S 1770 Van, Silane, triethoxy(2-(7-oxabicyclo(4.1.0)hept-3-yl)ethyl)-, Silquest Wetlink 90, Tci-T 3585, Triethoxy[2-(7-Oxabicyclo[4.1.0]Hept-3-Yl)Ethyl]Silane, Wetlink 90, Y 11870, beta-(3,4-Epoxycyclohexyl)ethyltriethoxysilane, β-(3,4-Epoxycyclohexyl)ethyltriethoxysilane
• CAS: 10217-34-2

Description

2-(3,4-epoxycyclohexyl)ethyltriethoxysilane is an antibacterial agent with ruthenium complex that is encapsulated and stabilized. It has been shown to be effective against a variety of bacteria, including methicillin-resistant Staphylococcus aureus and Escherichia coli. 2-(3,4-epoxycyclohexyl)ethyltriethoxysilane has been shown to inhibit the growth of metastatic cancer cells in a dose-dependent manner by binding to DNA and inhibiting the enzyme topoisomerase II. This inhibition results in the formation of free radicals, which induce damage to the tumor cell's DNA and stop its progression. 2-(3,4-epoxycyclohexyl)ethyltriethoxysilane also has chemotherapeutic effects for cancer cells by inducing apoptosis (cell death).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 288.46 g/mol
• Formule: C₁₄H₂₈O₄Si
• Degré de pureté: Min. 95%